Cargando…
Guillain-Barré Syndrome Following the Administration of Adenovirus Vector-Based COVID-19 Vaccine
As countries worldwide deployed their respective coronavirus disease 2019 (COVID-19) vaccination programs to mitigate the risk of COVID-19 to their citizens, several side effects and complications from the use of the various types of COVID-19 vaccines were documented and are continued to be monitore...
Autores principales: | Lee, Mardy L, Bautista, Juan Miguel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442713/ https://www.ncbi.nlm.nih.gov/pubmed/37614248 http://dx.doi.org/10.7759/cureus.42316 |
Ejemplares similares
-
Neurological Consequences of COVID-19: A Curious Case of Delayed Onset Guillain-Barre
por: Devarakonda, Aditya K, et al.
Publicado: (2022) -
Staphylococcus epidermidis Bacteremia in an Older Patient With Guillain-Barré Syndrome With Fever of Unknown Origin: A Case Report
por: Nagayama, Tomoe, et al.
Publicado: (2023) -
Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021) -
Guillain–Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain–Barré syndrome
por: Ling, Ling, et al.
Publicado: (2021) -
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1
por: Patel, Shreena Umit, et al.
Publicado: (2021)